1 / 17

Admissions to Substance Abuse Treatment for the Abuse of Opioid Analgesics: Findings from the Treatment Episode Data Set

Admissions to Substance Abuse Treatment for the Abuse of Opioid Analgesics: Findings from the Treatment Episode Data Set. Deborah Trunzo Office of Applied Studies Substance Abuse and Mental Health Services Administration November 13, 2008. Treatment Episode Data Set (TEDS).

beck
Télécharger la présentation

Admissions to Substance Abuse Treatment for the Abuse of Opioid Analgesics: Findings from the Treatment Episode Data Set

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Admissions to Substance Abuse Treatment for the Abuse of Opioid Analgesics:Findings from theTreatment Episode Data Set Deborah Trunzo Office of Applied Studies Substance Abuse and Mental Health Services Administration November 13, 2008

  2. Treatment Episode Data Set (TEDS) • Client-level information on treatment admissions • Collected by States and reported to SAMHSA • Primarily from facilities receiving public funds • Estimated coverage – 80% • 1.8 million admissions annually 2

  3. TEDS Data Elements • Demographic variables • Drug use history • top 3 substances of abuse at admission • route of administration • frequency of use • age at first use • Treatment variables 3

  4. Limitations of TEDS • Drugs of abuse reported in “generic” categories, not specific brand names or formulations • All States report on “opiates other than heroin” as a group • Only 16 States report on specific opioid analgesics 4

  5. Treatment Admissions by Primary Substance: 2006 N = 1.8 million * Includes admissions where primary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 5

  6. Treatment Admissions Involving Opioid Analgesics11992-2006 OxyContin introduced 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 6

  7. Percent Increase in Admissions for Heroin and Opioid Analgesics1:1997-2006 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 7

  8. Admissions Involving Specific Opioid Analgesics1: 2006 1Data submitted by 16 States: AL, HI, ID, KY, MD, ME, MO, MS, ND, NH, NJ, NM, NV, NY, OH, SD 8

  9. States Reporting Specific Opioid Analgesics: 2006 9 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  10. Percent Increase in Admissions for Specific Opioid Analgesics1:2000-2006 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. Analysis restricted to 13 States that reported detailed drug codes for 2000 and 2006. 10

  11. Proportion of Opioid Analgesic1 Admissions by State: 2006 < 5% 6-7% > 16% No data 5% 8-9% 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 11

  12. Opioid Analgesic1 Treatment Admission Rates by Urbanization: 2000 and 2006 MSA = Metropolitan Statistical Area 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 12

  13. Percent of Primary and Secondary Opioid Analgesic Admissions Using Other Substances: 2006 13

  14. Treatment Admissions Involving Opioid Analgesics1 by Age and Route of Administration: 2006 Oral Inhaled Injected Other Age 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 14

  15. Treatment Admissions Involving Oxycodone1 by Age and Route of Administration: 2006 Oral Injected Inhaled Other Age 1 Includes admissions where primary, secondary, or tertiary substance was reported as Oxycodone. 15

  16. Characteristics of Opioid Analgesic1 Admissions1997 and 2006 1 Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 16

  17. Admissions for Primary Opioid Analgesics1 by Age of First Use: 1997-2006 55+ 45 - 54 35 - 44 25 - 34 18 - 24 17 and under * Includes admissions where primary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. 17

More Related